- Home
- HSPO vs PDSB Comparison
HSPO vs PDSB Comparison
Compare HSPO & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSPO
- PDSB
- Stock Information
- Founded
- HSPO 2014
- PDSB 2005
- Country
- HSPO United States
- PDSB United States
- Employees
- HSPO N/A
- PDSB N/A
- Industry
- HSPO Blank Checks
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- HSPO Finance
- PDSB Health Care
- Exchange
- HSPO Nasdaq
- PDSB Nasdaq
- Market Cap
- HSPO 89.0M
- PDSB 84.2M
- IPO Year
- HSPO 2022
- PDSB N/A
- Fundamental
- Price
- HSPO $11.36
- PDSB $1.96
- Analyst Decision
- HSPO
- PDSB Strong Buy
- Analyst Count
- HSPO 0
- PDSB 3
- Target Price
- HSPO N/A
- PDSB $14.00
- AVG Volume (30 Days)
- HSPO 41.8K
- PDSB 403.5K
- Earning Date
- HSPO 01-01-0001
- PDSB 11-14-2024
- Dividend Yield
- HSPO N/A
- PDSB N/A
- EPS Growth
- HSPO 2.63
- PDSB N/A
- EPS
- HSPO 0.28
- PDSB N/A
- Revenue
- HSPO N/A
- PDSB N/A
- Revenue This Year
- HSPO N/A
- PDSB N/A
- Revenue Next Year
- HSPO N/A
- PDSB N/A
- P/E Ratio
- HSPO $40.32
- PDSB N/A
- Revenue Growth
- HSPO N/A
- PDSB N/A
- 52 Week Low
- HSPO $10.68
- PDSB $1.53
- 52 Week High
- HSPO $11.44
- PDSB $6.68
- Technical
- Relative Strength Index (RSI)
- HSPO 57.44
- PDSB 37.12
- Support Level
- HSPO $11.30
- PDSB $1.78
- Resistance Level
- HSPO $11.44
- PDSB $2.05
- Average True Range (ATR)
- HSPO 0.02
- PDSB 0.17
- MACD
- HSPO 0.00
- PDSB 0.02
- Stochastic Oscillator
- HSPO 42.86
- PDSB 26.47
About HSPO Horizon Space Acquisition I Corp.
Horizon Space Acquisition I Corp is a blank check company.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.